FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/26/2024
Back to search
Official data from USPTO
ACORV
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
03/26/2024
Trademark type
Word
Nice classes
1, 5, 42
Filing date
05/05/2022
Registration date
11/28/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/28/2023
Last transaction
11/28/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
FR
Examiner
OSGOOD, KRYSTINA
Law office
N30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
SANOFI
Representatives
Karen Lim Fross Zelnick Lehrman & Zissu, P.C.
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical preparations used in the manufacture of pharmaceutical products; biological compounds being biological preparations used in the manufacture of pharmaceutical productsantibodies
Class 5
Pharmaceutical preparations for the treatment of rare diseasesrare blood disordersoncologicimmunologicneurologic diseases and disorders; monoclonal and polyclonal antibodies for medical purposes; diagnostic preparations for medical and veterinary use; biological tissue cultures for medical and veterinary use
Class 42
Scientific research and laboratory research services in the field of biotechnology; biotechnical research; advice being consulting services in the field of biotechnologybacteriological researchbiological researchresearch and development of new pharmaceutical products and new component products for third partiesmedical and scientific researchconducting clinical trials for otherschemical analysis and research servicesmedical researchpharmaceutical research services
Publications
History of USPTO decisions and trademark events.
29 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/29/2024
FIMP
FINAL DISPOSITION PROCESSED
02/29/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/28/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
12/11/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/28/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
11/28/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/22/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
11/22/2023
GPNX
NOTIFICATION PROCESSED BY IB
09/12/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/12/2023
PUBO
PUBLISHED FOR OPPOSITION
09/12/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/23/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/23/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/23/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/10/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/04/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/04/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/04/2023
RFNT
REFUSAL PROCESSED BY IB
05/10/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/17/2023
RFRR
REFUSAL PROCESSED BY MPU
04/17/2023
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
03/17/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/25/2023
CNRT
NON-FINAL ACTION WRITTEN
02/24/2023
DOCK
ASSIGNED TO EXAMINER
02/23/2023
MAFR
APPLICATION FILING RECEIPT MAILED
06/21/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/17/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/16/2022
Continuous trademark protection
Get notified about every new filing that threatens ACORV or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.